SkinVision
AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.
Last updated: June 5, 2026
Back to directoryClinical AI symptom-assessment and care-navigation platform for digital front door and patient-routing workflows.
Organizations that need structured symptom collection, acuity-aware routing, and handoff reports before clinical or access-team review.
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ada Health as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm which Ada product and geography are in scope, because Ada positions some enterprise flows as regulated symptom-assessment technology and says jurisdiction-specific limits still need to be verified. |
|---|---|
| Privacy | Ada publishes privacy and compliance claims, but the deployment review still needs to cover consent, partner data sharing, retention, automated-decision boundaries, and any HIPAA or regional health-data obligations. |
| Evidence | Use published studies and enterprise claims as supporting context only; validate routing accuracy, false reassurance risk, escalation quality, and handover usefulness in your own population and service map. |
| Workflow | Define how symptom assessment, care navigation, and clinician or access-team handover connect so users are not left with ambiguous next steps or delayed escalation. |
Ada describes enterprise symptom assessment, care navigation, clinical handover, and insights; its help and privacy pages state that Ada is not a substitute for medical advice and that Ada Assess is registered as an EU MDR Class IIa medical device, with jurisdiction-specific limits to verify.
Not for: Emergency diagnosis, final medical advice, autonomous treatment decisions, or use outside product-specific regulatory and regional limits.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.